Elliott Dasenbrook, MD
Cystic FibrosisPulmonology
Highlights
Age Groups Seen
- Child
- Adolescent
- Adult
Languages
- English
Gender
MaleAbout Elliott Dasenbrook
Biography
Elliott Dasenbrook, MD MHS, is the Director of the Cleveland Clinic Adult Cystic Fibrosis Program and the Bronchiectasis Center in the Respiratory Institute. Dr. Dasenbrook trained in the care of individuals living with cystic fibrosis at Johns Hopkins Hospital under the mentorship of Dr. Michael Boyle. Dr. Dasenbrook is known around the world for his expertise in the management of difficult to treat infections. As a member of a multidisciplinary CF team at the Cleveland Clinic, Dr. Dasenbrook partners with his patients to meet their individual goals in order to optimize health outcomes. He has been involved in the care of individuals with CF for more than 10 years and believes that the most important member of the CF team is the patient.
Dr. Dasenbrook is a member of the National Cystic Fibrosis Access to Care Committee which is comprised of patients, family members, and clinicians to identify barriers and solutions to improve access to care in the United States. He also participates in Research and is the Associate Chair of the National CF Foundation Patient Registry Committee.
For more information about the Cleveland Clinic CF program or an appointment, please call 216.442.4623 (GOCF)
Dr. Dasenbrook has taken the skills he has learned in the care of cystic fibrosis lung disease and applied it to individuals with bronchiectasis and pulmonary nontuberculous mycobacteria (NTM) infectious such as Mycobacterium avium complex (MAC) and Mycobacterium abscessus. The focus in this clinic is diagnosing the underlying cause of bronchiectasis (such as primary ciliary dyskinesia (PCD)) and expert management of bronchiectasis lung disease.
The goal of the clinic is to improve patient day to day quality of life through reduction of daily cough, mucus production, and number of respiratory exacerbations. To achieve these goals, the Bronchiectasis team at the Cleveland Clinic has advanced knowledge in airway clearance techniques and devices, inhaled medications to treat airway infections, and treatment of airway inflammation. For patients who have NTM, Dr. Dasenbrook collaborates with his colleagues from Infectious Disease who also specialize in treatment of pulmonary NTM. In addition to clinical care, Dr. Dasenbrook is active in research for non-CF bronchiectasis.
Request Second Opinion
Get the peace of mind you deserve. When it matters most, you can count on a second opinion from the experts at Cleveland Clinic. Find answers. Feel confident. Get a Second Opinion.
Education & Board Certifications
Education
- Fellowship: Johns Hopkins University School of Medicine, 2009
- Residency: Loyola University Stritch School of Medicine, 2005
- Medical Education: Loyola University Stritch School of Medicine, 2001
- Undergraduate: Loyola University, 1997
Board Certifications
- Critical Care Medicine: American Board of Internal Medicine, 2012
- Pulmonary Disease: American Board of Internal Medicine, 2009
Innovations & Patents
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-08-06, Dr. Dasenbrook has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.